The Carlyle Group
Founded in 1987, Carlyle targets companies in healthcare and many other industries. With its U.S. headquarters in Washington, D.C., the firm has 21 buyout funds and 11 growth capital funds. U.S. healthcare companies in Carlyle’s portfolio include AcuFocus, developer of a surgical implant for the correction of presbyopia (age-related farsightedness); ConvaTec, a developer and marketer of medical technologies in areas including wound and skin care, ostomy care, continence and critical care, and infusion devices; Ortho-Clinical Diagnostics, a provider of solutions for screening, diagnosing, monitoring and confirming diseases; and Proteus Digital Health, a developer of products focused on improving congestive heart failure therapy.
